Effects of HIIT on Metabolic Syndrome
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04133129|
Recruitment Status : Not yet recruiting
First Posted : October 21, 2019
Last Update Posted : October 21, 2019
|Condition or disease||Intervention/treatment||Phase|
|Dyslipidemias Metabolic Syndrome Sedentary Behavior Obesity Blood Pressure||Behavioral: Low Volume-High Intensity Interval Training Behavioral: Moderate Intensity Continuous Training||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||180 participants|
|Intervention Model:||Parallel Assignment|
|Intervention Model Description:||Participants are only assigned to one of 3 possible groups for the duration of the intervention.|
|Masking:||None (Open Label)|
|Official Title:||Study of the Effects of a Structured Training Program on People at Risk of Developing Metabolic Syndrome|
|Estimated Study Start Date :||November 1, 2019|
|Estimated Primary Completion Date :||March 2, 2020|
|Estimated Study Completion Date :||March 31, 2020|
Experimental: LV-High Intensity Interval Training
2 x 4 minutes at 85%-95% of Heart rate max.
Behavioral: Low Volume-High Intensity Interval Training
On a treadmill, a 2 minute warm-up will be followed by 2 bouts of 4 minutes at an intensity between 85% and 95% of Maximum Heart Rate (HRmax) interspersed by a 2 minutes recovery bout at 70% of heart rate max, followed by a 3 minutes Cool Down
Experimental: Moderate Intensity Continuous Training
1 x 45 minutes at 65%-75% of Heart rate max.
Behavioral: Moderate Intensity Continuous Training
On a treadmill,a 2-minute warm-up will be followed by 45 minutes at 65%-75% of Heart Rate max followed by 3 minutes cool down.
Other Name: MICT
No Intervention: Control Group
They will not be prescribed any training and will be asked to continue with their normal lifestyle.
- Biochemical: Lipid Profile [ Time Frame: 0 to 12 weeks ]Evaluate change in Very Low-Density Lipoproteins (VLDL), High Density Lipoprotein (HDL), and Low-Density Lipoprotein (LDL) in (mg/dl) with Liposcale® test, an advanced lipoprotein test based on 2D Nuclear Magnetic Resonance (NMR).
- Blood Pressure (mmHg) [ Time Frame: 0 to 12 weeks ]Evaluate change in Systolic and Diastolic Blood Pressure
- Cardiorespiratory Fitness (ml/kg/min) [ Time Frame: 0 to 12 weeks ]Evaluate change in maximal oxygen uptake (VO2max) via breath by breath analysis performed on a treadmill.
- Changes in Body Composition (kg) [ Time Frame: 0 to 12 weeks ]Evaluate changes in Fat-free mass, fat mass, skeletal muscle mass measured by bio-electrical impedance analysis.
- Changes in exercise enjoyment [ Time Frame: 0 to 12 weeks ]The investigators will assess perceived exercise enjoyment at baseline and post intervention using The Physical Activity Enjoyment Scale (PACES). (PACES) is an 18-item measure, scored on a 7-point bipolar scale based on the instruction; "Please rate how you feel at the moment about the physical activity you have been doing:"
- Change in Behavioural Regulations in Exercise Questionnaire-2 (BREQ-2) over time [ Time Frame: 0 to 12 weeks ]Behavioural Regulations in Exercise Questionnaire-2 (BREQ-2) is a 19 item self-report scale. It uses a Likert-type scale of 5 points, where 0 = not true for me and 4 = very true for me
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04133129
|Contact: Ismael Serrablo, MScfirstname.lastname@example.org|
|CDM GO fit Vallehermoso||Not yet recruiting|
|Madrid, Spain, 28003|
|Principal Investigator: Ismael Serrablo, MsC|
|Study Director:||Elizabeth Horton, PhD||Coventry University|
|Study Director:||Alfonso Jimenez, PhD||GOfit and Sheffield Hallam University|
|Principal Investigator:||Ismael Serrablo, MSc||Coventry University|